Maynard Um
-
-
-
-
-
-
-
BTIG Downgrades Hims and Hers (HIMS) to Neutral
-
-
-
-
-
-
-
Hims & Hers Health Inc. set to report Q4 earnings with guidance cut fears mounting after compounded semaglutide fallout
-
-
-
-
-
-
-
Novo Nordisk jumps, Hims shares plummet after pulling $49 weight-loss pill
-
-
-
-
-
-
-
Hims & Hers stock falls after FDA warns against illegal copycat drugs
-
-
-
-
-
-
-
BMO Capital: 'Novo Mgmt Meetings Highlight Deep Strategic Challenges'
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Lowered to $29 at BofA Securities, 'Sales and EBITDA margin expectations are too high'
-
-
-
-
-
-
-
Novo Nordisk cuts cash prices for Wegovy and Ozempic to $199 monthly
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

